Safety and effectiveness of dabigatran vs rivaroxaban in nonvalvular atrial fibrillation patients at nutritional risk.
- DOI
- 10.1016/j.rpth.2026.106865
- Published
- 2026 Jul
- Container
- Research and practice in thrombosis and haemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rpth.2026.106865,
title = {Safety and effectiveness of dabigatran vs rivaroxaban in nonvalvular atrial fibrillation patients at nutritional risk.},
author = {Liu L and Liu H and Aa G and Yang J and Zhang Z and Yang T and Sun B and Zuo L and Qin H and Liu S and Sia CH and Sun P and Yang Q and Zhou X},
year = {2026},
journal = {Research and practice in thrombosis and haemostasis},
doi = {10.1016/j.rpth.2026.106865},
url = {https://doi.org/10.1016/j.rpth.2026.106865}
}RIS
TY - JOUR TI - Safety and effectiveness of dabigatran vs rivaroxaban in nonvalvular atrial fibrillation patients at nutritional risk. AU - Liu L AU - Liu H AU - Aa G AU - Yang J AU - Zhang Z AU - Yang T AU - Sun B AU - Zuo L AU - Qin H AU - Liu S AU - Sia CH AU - Sun P AU - Yang Q AU - Zhou X PY - 2026 JO - Research and practice in thrombosis and haemostasis DO - 10.1016/j.rpth.2026.106865 UR - https://doi.org/10.1016/j.rpth.2026.106865 ER -
APA
L, L., H, L., G, A., J, Y., Z, Z., T, Y., B, S., L, Z., H, Q., S, L., CH, S., P, S., Q, Y., & X, Z. (2026). Safety and effectiveness of dabigatran vs rivaroxaban in nonvalvular atrial fibrillation patients at nutritional risk.. Research and practice in thrombosis and haemostasis. https://doi.org/10.1016/j.rpth.2026.106865
Source records
- pubmed · retrieved 2026-09-26T13:14:18.856Z